Ischemic stroke is the third leading cause of death after heart disease and cancer. Department of Neurology, comply with the need of the dev
Ischemic stroke is the third leading cause of death after heart disease and cancer. Department of Neurology, comply with the need of the development of medical technology, the establishment of cerebrovascular disease group, and constantly develop new technologies, new therapies, including the following: (1) the cerebral angiography technique can detect the CT, MRI was not detected in the vascular lesions, such as vascular stenosis location and length, cerebral aneurysm and arteriovenous malformation the site of occlusion, etc., provide accurate basis for interventional therapy.
(2) acute cerebral infarction early interventional thrombolysis, thrombectomy this technique can make the vascular occlusion of the cerebral infarction patients with short term recanalization, avoid the adverse consequences of previous cerebral infarction patients after hospital treatment may still have death or aphasia, hemiplegia, and postoperative hospitalization time can be shortened to 3 days; arrive at the hospital 6 hours after the onset of the technical requirements, the sooner the better.
(3) carotid artery stenosis is an important cause of long-term dizziness headache, cerebral infarction risk factors and causes, symptoms of stent assisted angioplasty can obviously improve the patients, greatly reduce the incidence of cerebral infarction.
The above technology has the essential difference compared with the traditional medicine treatment, and is the new technology which obtains the biggest treatment effect with the smallest treatment wound.
Indications: 1, under the age of 80 years, no serious heart, liver, kidney dysfunction.
2. The onset time of carotid artery system was within 6 hours, and the vertebral basilar artery system was within 12 hours.
3, there are obvious neurological dysfunction, and gradually increased; CT no low density foci, and exclude cerebral hemorrhage or other significant intracranial lesions.
4, no bleeding tendency, coagulation function is normal.
5, family members signed consent.
Absolute contraindications: 1, pure sensory disorder or ataxia.
2, clinical symptoms quickly improve.
3, active intracranial hemorrhage.
4, bleeding diathesis or hemorrhagic disease
5, intracranial aneurysm, arteriovenous malformation, intracranial tumor or suspected subarachnoid hemorrhage.
6, bleeding history.